Serum levels of LDH, CEA, and CA19-9 have prognostic roles on survival in patients with metastatic pancreatic cancer receiving gemcitabine-based chemotherapy

被引：0
|
作者：
Faruk Tas
Senem Karabulut
Rumeysa Ciftci
Fatma Sen
Burak Sakar
Rian Disci
Derya Duranyildiz
机构：
[1] Istanbul University,Institute of Oncology
来源：
Cancer Chemotherapy and Pharmacology | 2014年 / 73卷
关键词：
LDH; CEA; CA19-9; Metastatic; Pancreatic cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1163 / 1171
页数：8
相关论文
共 50 条
  • [1] Serum levels of LDH, CEA, and CA19-9 have prognostic roles on survival in patients with metastatic pancreatic cancer receiving gemcitabine-based chemotherapy
    Tas, Faruk
    Karabulut, Senem
    Ciftci, Rumeysa
    Sen, Fatma
    Sakar, Burak
    Disci, Rian
    Duranyildiz, Derya
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (06) : 1163 - 1171
  • [2] Prognostic values of serum CA19-9 and CEA levels for colorectal cancer
    Nakayama, T
    Watanabe, M
    Teramoto, T
    Kitajima, M
    ONCOLOGY REPORTS, 1997, 4 (04) : 819 - 822
  • [3] Evaluation of serum CEA and CA19-9 levels as prognostic factors in patients with gastric cancer
    Kochi M.
    Fujii M.
    Kanamori N.
    Kaiga T.
    Kawakami T.
    Aizaki K.
    Kasahara M.
    Mochizuki F.
    Kasakura Y.
    Yamagata M.
    Gastric Cancer, 2000, 3 (4) : 177 - 186
  • [4] Relationship between serum CA19-9 and CEA levels and prognosis of pancreatic cancer
    Wu, Lei
    Huang, Peijun
    Wang, Fang
    Li, Daqian
    Xie, Erfu
    Zhang, Yan
    Pan, Shiyang
    ANNALS OF TRANSLATIONAL MEDICINE, 2015, 3 (21)
  • [5] CA19-9 as a predictor of tumor response and survival in patients with advanced pancreatic cancer treated with gemcitabine based chemotherapy
    Hammad, Nazik
    Heilbrun, Lance K.
    Philip, Philip A.
    Shields, Anthony F.
    Zalupski, Mark M.
    Venkatramanamoorthy, Raghu
    El-Rayes, Bassel F.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2010, 6 (02) : 98 - 105
  • [6] Prognostic value of serum CEA and CA19-9 levels in pancreatic ductal adenocarcinoma
    Ermiah, Eramah
    Eddfair, Mona
    Abdulrahman, Othman
    Elfagieh, Mohamed
    Jebriel, Abdalla
    Al-Sharif, Mona
    Assidi, Mourad
    Buhmeida, Abdelbaset
    MOLECULAR AND CLINICAL ONCOLOGY, 2022, 17 (02)
  • [7] Elevated CEA and CA19-9 serum levels independently predict advanced pancreatic cancer at diagnosis
    van Manen, Labrinus
    Groen, Jesse V.
    Putter, Hein
    Vahrmeijer, Alexander L.
    Swijnenburg, Rutger-Jan
    Bonsing, Bert A.
    Mieog, J. Sven D.
    BIOMARKERS, 2020, 25 (02) : 186 - 193
  • [8] Serum CA19-9 Decline Compared to Radiographic Response as a Surrogate for Clinical Outcomes in Patients With Metastatic Pancreatic Cancer Receiving Chemotherapy
    Wong, Derrick
    Ko, Andrew H.
    Hwang, Jimmy
    Venook, Alan P.
    Bergsland, Emily K.
    Tempero, Margaret A.
    PANCREAS, 2008, 37 (03) : 269 - 274
  • [9] Comorbidity, not age, is prognostic in patients with advanced pancreatic cancer receiving gemcitabine-based chemotherapy
    Nakai, Yousuke
    Isayama, Hiroyuki
    Sasaki, Takashi
    Sasahira, Naoki
    Tsujino, Takeshi
    Kogure, Hirofumi
    Yagioka, Hiroshi
    Yashima, Yoko
    Togawa, Osama
    Arizumi, Toshihiko
    Matsubara, Saburo
    Hirano, Kenji
    Tada, Minoru
    Omata, Masao
    Koike, Kazuhiko
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2011, 78 (03) : 252 - 259
  • [10] An evaluation of the diagnostic value of CA19-9 and CEA levels in patients with pancreatic cancer
    Zhenhua Ma
    The Journal of Biomedical Research, 2009, (03) : 199 - 202
12345